Physicochemical properties, in vitro release and in vivo evaluation of tramadol hydrochloride rectal suppository and rectal gel

1. Dayer P, Collart L, Desmeules J. The pharmacology of tramadol. Drugs. 1994; 47(Suppl):3-7.10.2165/00003495-199400471-00003Search in Google Scholar

2. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004; 43:879-923.10.2165/00003088-200443130-00004Open DOISearch in Google Scholar

3. Micromedex Healthcare Series: Document 2007. Tramadol. Available from: http://www.thomsonhc.com/hcs/librarian/ND_PR/Main/SBK/3/PFPUI/7z16hW4.Search in Google Scholar

4. Petrone D, Kamin M, Olson W. Slowing the titration rate of tramadol HCl reduces the incidence of discontinuation due to nausea and/ or vomiting: a double-blind randomized trial. J Clin Pharm Ther. 1999; 24:115-23.10.1046/j.1365-2710.1999.00203.xOpen DOISearch in Google Scholar

5. Mercadante S, Arcuri E, Fusco F, Tirelli W, Villari P, Bussolino C, Campa T, De Conno F, Ripamonti C. Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-na_ve cancer patients with pain. Support Care Cancer. 2005; 13:702-7.10.1007/s00520-004-0760-9Open DOISearch in Google Scholar

6. Allen LV Jr. Compounding suppositories. Part I: theoretical considerations. Int J Pharm Compound. 2000; 4:289-93.Search in Google Scholar

7. MIMS Thailand Index of Medical Specialties, 115th Edition, 2009.Search in Google Scholar

8. British Pharmacopoeia 2007. CD version 11.0.Search in Google Scholar

9. Yong CS, Oh YK, Jung SH, Rhee JD, Kim HD, Kim CK, Choi JS, Choi HG. Preparation of ibuprofen-loaded liquid suppository using eutectic mixture system with menthol. Eur J Pharm Sci. 2004; 23:347-53.10.1016/j.ejps.2004.08.008Open DOISearch in Google Scholar

10. Woolfe G, MacDonald AD. The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther. 1944; 80:300-7.Search in Google Scholar

11. Yun MO, Choi HG, Jung JH, Kim CH. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement. Int J Pharm. 1999; 189: 137-45.10.1016/S0378-5173(99)00227-6Search in Google Scholar

12. Allen, LV Jr. Featured excipient: The poloxamers. Int J Pharm Compound. 2002; 6:58-9.Search in Google Scholar

13. Miller SC, Drabik BR Rheological properties of poloxamer vehicles. Int J Pharm. 1984; 18:269-79.10.1016/0378-5173(84)90142-XOpen DOISearch in Google Scholar

14. Choi HG, Lee MK, Kim MH, Kim CK. Effects of additives on the physicochemicasl properties of liquid suppository bases. Int J Pharm.1999; 190:13-9.10.1016/S0378-5173(99)00225-2Search in Google Scholar

15. Barakat NS. In vitro and in vivo charecteristics of thermogelling rectal drug delivery. AAPS PharmSciTech. 2004; 10:724-31.10.1208/s12249-009-9261-yOpen DOISearch in Google Scholar

16. Choi HG, Oh YK, Kim CK. In-situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. Int J Pharm. 1998; 165:23-32.10.1016/S0378-5173(97)00385-2Search in Google Scholar

17. Hewitt WD. Compounded suppositories and pharmaceutical care. Int J Pharm Compound. 1997; 1: 93-9.Search in Google Scholar

18. Hosny EA, Abdeel-Hady SS, El-Tahir K. Formulation, in vitro release and ex vivo spasmolytic effects of mebeverine hydrochloride suppositories containing polycarbophil or polysorbate 80. Int J Pharm. 1996; 142:163-8.10.1016/0378-5173(96)04664-9Search in Google Scholar

19. LeBars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev. 2001; 53:597- 652.Search in Google Scholar

20. Sacerdote P, Bianchi M, Manfredi B, Panerai AE. Effects of tramadol on immune response and nociceptive thresholds in mice. Pain.1997; 72:325-30. 10.1016/S0304-3959(97)00055-9Search in Google Scholar